JP MORGAN/PUT/BECTON DICKINSON AND CO./230/0.1/16.08.24 Share Price

Warrant

DE000JT1EQX5

Real-time Bid/Ask 14:13:01 03/07/2024 BST
1.03 EUR / 1.09 EUR -2.75% Intraday chart for JP MORGAN/PUT/BECTON DICKINSON AND CO./230/0.1/16.08.24
Current month+7.92%
1 month-22.14%
Date Price Change
03/07/24 1.03 -5.50%
02/07/24 1.09 +25.29%
01/07/24 0.87 -13.86%
28/06/24 1.01 +3.06%
27/06/24 0.98 +18.07%

Delayed Quote Börse Stuttgart

Last update July 03, 2024 at 11:02 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellPUT
Underlying BECTON, DICKINSON AND COMPANY
Issuer J.P. Morgan
WKN JT1EQX
ISINDE000JT1EQX5
Date issued 23/05/2024
Strike 230 $
Maturity 16/08/2024 (44 Days)
Parity 10 : 1
Emission price 0.57
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.51
Lowest since issue 0.75
Spread 0.06
Spread %5.41%

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
229.2 USD
Average target price
278.9 USD
Spread / Average Target
+21.65%
Consensus